Evaluation of medical practices. The case for technology assessment.
We believe that the systematic evaluation of medical practices, especially those that are risky or costly deserves more attention. Available methods are limited, and definitive assessments of innovative or controversial practices are infrequent. Nevertheless, some evaluations have successfully enhanced the use of effective practices and diminished the reliance on ineffective ones. Greater efforts at evaluation can improve the quality of patient care, avoid waste and promote the more rational use of health resources. The cost of assessing new practices should be viewed as an intrinsic part of the cost of medical care. Physicians and medical societies bear primary responsibility for recognizing the need for this evaluation, for enlisting other experts, participating in technology assessment and working to translate the results of evaluation into practice. The commitment of government agencies, insurance companies and teaching institutions is also essential to an effective program of evaluation.
D000328:Adult; D003363:Cost Control; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic; D005260:Female; D005102:Health Expenditures; D006295:Health Resources / Q000191:economics / Q000600:supply & distribution; D006301:Health Services Needs and Demand; D006801:Humans; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011787:Quality of Health Care; D011878:Radiotherapy / Q000009:adverse effects; D012306:Risk; D013673:Technology Assessment, Biomedical; D013812:Therapeutics / Q000592:standards; D014481:United States